News

Filter

Current filters:

Alitretinoin

1 to 9 of 51 results

UK's NICE issues chronic hand eczema appraisal doc

08-05-2009

The National Institute for Health and Clinical Excellence (NICE), which determines which drugs should…

AlitretinoinPanretin

Stock Commentary - Europe - week to mar 30, 2009

02-04-2009

EUROPEAN: bourses were all sharply lower, falling first on profit-taking then plunging dramatically on…

AlitretinoinAllerganAspirinAstraZenecaAventis PharmaBayerBayerGlaxoSmithKlineGSKLundbeckMerck KGaANovartisPanretinRocheSanofi-Aventis

Basilea submits Toctino MAA to 15 additional European countries

02-04-2009

Swiss drugmaker Basilea Pharmaceutica has submitted a Marketing Authorization Application for Toctino…

AlitretinoinNystatinOralPanretin

Stock Commentary - Europe - week to Mar 9, 2009

16-03-2009

EUROPEAN: bourses continued depressed for yet another reporting period to March 9, with little to cheer…

AlitretinoinAstraZenecaAventis PharmaGenentechMerck KGaAPanretinRocheSanofi-AventisSchering PloughSchering-PloughShireUCB

Basilea's Toctino cleared by SMC

16-03-2009

Switzerland-based firm Basilea Pharmaceutica's Toctino (alitretinoin), an oral capsule for the treatment…

AlitretinoinNystatinOralPanretin

UK release for Basilea's Toctino

22-09-2008

Switzerland-based firm Basilea Pharmaceutica has released its Toctino (alitretinoin) oral capsule for…

AlitretinoinAquasol ANystatinOralPanretinVitamin A

Basilea eczema drug's UK price twice estimate

15-09-2008

Basel, Switzerland-based firm Basilea Pharmaceutica has received the first marketing authorization in…

AlitretinoinNystatinOralPanretin

ABPI joined by 16 new members in 1H 2008

04-08-2008

The Association of the British Pharmaceutical Industry has announced that, for the first half of 2008,…

AlitretinoinJohnson & JohnsonPanretin

1 to 9 of 51 results

COMPANY SPOTLIGHT

Menarini

Back to top